ABOUT US

Unizima is catalysing the
decentralized manufacturing
of medicines

BIOLOGICS FOR ALL

The gap between scientific innovation and accessibility of medicines has continued to grow

Global supply chains for the manufacturing and distribution of vital biologics are broken. The fault lines in access to biologics, particularly in the Global South, were amplified by the Covid-19 pandemic. There is growing consensus that the collective vision of a more equitable and resilient world is unattainable without a new approach to biomanufacturing.

shutterstock_2015750855

Providing
end-to-end
solutions for your biomanufacturing needs

shutterstock_2015750855

PROVIDING END-TO-END SOLUTIONS FOR YOUR
BIOMANUFACTURING NEEDS

Unizima is a biomanufacturing services and technology provider embedded within the global health space, providing the expertise and technology needed to enable sustainable production of biologics such as vaccines, monoclonal antibodies and insulin in new regions.

We serve as a trusted partner for biopharma manufacturers, governments and global health agencies to make biologics production in low- and middle-income countries (LMICs) and emerging markets a reality.

We are driven by the end goal of delivering life-changing biologics to people who would otherwise lack access to them. We are part of the Univercells Group and share its ground-breaking technology and engineering innovations.

Biologics beyond borders

HOW CAN WE WORK TOGETHER?

advice-img

Advise

Unizima provides objective, strategic and technical advice to governments, multilateral institutions, manufacturers and funders covering the technical, financial and regulatory aspects of their biomanufacturing projects.

Design & Build

Turnkey solutions: We deliver end-to-end services for local partners to set up new, state of-the art biomanufacturing facilities, or to expand or upgrade capacity in existing facilities across the value chain, including R&D, drug substance and drug product sites

design-build-img
collaborate-img

Collaborate

We forge partnerships between public and private sector organisations including funders, global health agencies and biotech organizations to catalyse breakthrough approaches to biomanufacturing in LMICs and emerging markets

WHY PARTNER WITH US?

Unizima can add value to your projects in three distinct ways

Unizima Homepage Rapid Turnaround

Rapid Turnaround

We provide a full suite of services that includes strategy, product licensing, design and build of facilities and workforce development all in one place. This allows customers to accelerate the implementation and operations of their facility, delivering locally produced biologics

Homepage Icons Bioreactor

Technology-driven Affordability

We offer access to the next generation of bioproduction technologies and knowhow of the Univercells Group enabling low cost and low footprint production. The same principles of value engineering that created these ground-breaking technologies are applied to every project, to make them as economical and technologically innovative as possible.

Unizima Homepage Expertise Grounded in Reality

Expertise Grounded in Reality

Our team has extensive global experience in manufacturing strategy, investment profitability analysis, engineering, biologics manufacturing, GMP and Quality Assurance, Regulatory Affairs, supply chain, logistics management and recruitment Our solutions are designed by leveraging local expertise and networks to overcome the unique challenges to delivering complex projects in each region.

OUR TRACK REC0RD

Unizima Homepage Senegal
Senegal

Working with Institut Pasteur de Dakar, Unizima is providing recruitment, workforce development and operational support for the Manufacturing in Africa for Disease Immunisation and Building Autonomy (MADIBA) project, a first-of-its kind, modular African CDMO for vaccines. Funded by a coalition of international donors and governments, MADIBA will leverage Unizima’s expertise and Univercells’ equipment, to reach a capacity of 300 million doses/year for a range of epidemic and routine diseases.

Working with Institut Pasteur de Dakar, Unizima is providing recruitment, workforce development and operational support for the Manufacturing in Africa for Disease Immunisation and Building Autonomy (MADIBA) project, a first-of-its kind, modular African CDMO for vaccines. Funded by a coalition of international donors and governments, MADIBA will leverage Unizima’s expertise and Univercells’ equipment, to reach a capacity of 300 million doses/year for a range of epidemic and routine diseases.

Working with Institut Pasteur de Dakar, Unizima is providing recruitment, workforce development and operational support for the Manufacturing in Africa for Disease Immunisation and Building Autonomy (MADIBA) project, a first-of-its kind, modular African CDMO for vaccines. Funded by a coalition of international donors and governments, MADIBA will leverage Unizima’s expertise and Univercells’ equipment, to reach a capacity of 300 million doses/year for a range of epidemic and routine diseases.

Working with Institut Pasteur de Dakar, Unizima is providing recruitment, workforce development and operational support for the Manufacturing in Africa for Disease Immunisation and Building Autonomy (MADIBA) project, a first-of-its kind, modular African CDMO for vaccines. Funded by a coalition of international donors and governments, MADIBA will leverage Unizima’s expertise and Univercells’ equipment, to reach a capacity of 300 million doses/year for a range of epidemic and routine diseases.